Recro Pharma
REPH
#9472
Rank
NZ$0.22 B
Marketcap
NZ$3.82
Share price
-0.48%
Change (1 day)
-26.84%
Change (1 year)

Earnings for Recro Pharma (REPH)

Earnings in 2021 (TTM): NZ$5.41 Million

According to Recro Pharma 's latest financial reports the company's current earnings are NZ$75.36 Million. In 2020 the company made an earning of -NZ$15.2 Million a decrease over its 2019 earnings that were of NZ$44.66 Million.

Earnings history for Recro Pharma from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)NZ$5.41 M-135.65%
2020-NZ$15.2 Million-134.02%
2019NZ$44.66 M-145.64%
2018-NZ$97.86 Million34.08%
2017-NZ$72.99 Million55.21%
2016-NZ$47.03 Million258.83%
2015-NZ$13.11 Million-39.6%
2014-NZ$21.7 Million989.11%
2013-NZ$2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B 497,269.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$32.26 M 368.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.15 Billion-2,209.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$18.81 Million-373.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.12 Billion-1,768.23%๐Ÿ‡บ๐Ÿ‡ธ USA